The 257th Social Security Council, Long-Term Care Benefit Costs Subcommittee (Web Conference) to be Held

SUMMARY

According to a press release from the Ministry of Health, Labour and Welfare, "The 257th Social Security Council, Long-Term Care Benefit Costs Subcommittee" will be held. This information is relevant for management decisions concerning hospitals, clinics, and medical corporations, reflecting the latest trends in the healthcare industry.

📝 EDITOR'S NOTE — A Medical M&A Perspective

Trends in the medical industry directly impact the succession and M&A strategies of hospitals, clinics, and medical corporations. Changes in the complex management environment, such as revisions to medical fees, lack of successors, staffing shortages, burden of capital investment, and progress in regional medical plans, are forcing medical institutions to make new management decisions.

As an option for successor issues and changes in the management environment,Third-Party Succession M&Ais increasing in importance year by year. Choosing succession over closure or廃業 (business dissolution) allows for the simultaneous achievement of securing a transfer price, maintaining staff employment, ensuring continuity of patient care, and preserving regional medical services. The framework of M&A support institutions certified by the Small and Medium Enterprise Agency has also been established, and advisory services specializing in the unique licensing, tax, and labor issues of the medical industry have become widespread.

For medical institutions, accurately grasping industry trends and seeking early consultation with experts are key to attracting the best options for management decisions. As an M&A advisory firm specializing in the medical industry, we support medical institutions with free consultations and success-fee-based services.

News Highlights

On May 22, 2026, the 257th Social Security Council, Long-Term Care Benefit Costs Subcommittee was held. It is presumed that discussions towards the revision of long-term care benefits are progressing in this subcommittee. For managers, successors, and stakeholders of medical institutions, the trends in long-term care benefits directly impact revenue, making future revision details and discussion progress matters that require close attention.

M&A Medical Editorial Department’s Perspective

While the holding of this Social Security Council, Long-Term Care Benefit Costs Subcommittee meeting is not a direct announcement of medical M&A, it can be considered an important signal directly linked to maintaining and strengthening the “earning power” in medical institution management. In particular, the revision rate for long-term care benefits is determined in conjunction with policy trends such as regional medical care plans and the promotion of home-based medical care. For example, the FY2024 long-term care benefit revision included enhanced medical cooperation and evaluation for end-of-life and terminal care. Whether these evaluations are further expanded or new evaluation items are added in the current discussions will significantly affect the profitability of medical institutions strong in home-based care and palliative care. When considering M&A, a strategic perspective is essential, not just a simple “sell because it’s in the red” discussion, but rather restructuring the business portfolio with future benefit revisions in mind and shifting towards highly profitable areas.

Points Indicated by This News

Discussions on the revision of long-term care benefits directly impact the revenue structure of medical institutions.
Expansion of evaluations for medical cooperation and end-of-life/terminal care increases revenue opportunities for related businesses.
Policy trends such as regional medical care plans and the promotion of home-based medical care influence the direction of long-term care benefit revisions.
Reviewing business strategies with future benefit revisions in mind is key to managing medical institutions.

Practical Questions Arising from This News

What specific proposals for revising long-term care benefits are being discussed at this Long-Term Care Benefit Costs Subcommittee meeting?
What are the specific reasons why medical institutions should pay close attention to trends in long-term care benefit revisions?
Based on the discussions regarding the revision of long-term care benefits, what management strategies should medical institutions formulate?

If You Feel “Should I Consult Too?”

To what extent will your institution’s revenue structure be affected by future revisions to long-term care benefits? If there is a risk of revenue being squeezed by revisions, or conversely, if you are considering business expansion into areas where expanded evaluations are expected, reviewing management strategies through M&A or business succession may be a viable option. Why not consider the optimal next step by comparing your institution’s future vision with the trends in benefit revisions, together with experts?

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a complete success fee system as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here

📌 Source (Primary Information)

The 257th Social Security Council, Long

Source: Ministry of Health, Labour and Welfare Press Releases

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →